retatrutide case study Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care Retatrutide: Understanding Its Triple Receptor

Contact your doctor or healthcare team if you experience: Persistent or severe nausea, vomiting, or diarrhoea affecting your ability to eat, drink, or function normally Signs of dehydration from persistent gastrointestinal losses, such as dizziness, light-headedness, or significantly reduced urination Signs of pancreatitis , including severe upper abdominal pain that may radiate to the back call 999 or go to your nearest A&E immediately if pain is severe Gallbladder symptoms such as right upper abdominal pain, fever, or yellowing of the skin or eyes (jaundice) Symptoms of hypoglycaemia (low blood sugar) particularly if you are also taking diabetes medications such as insulin or sulphonylureas

Impact of liraglutide on amylase, lipase, and acute pancreatitis in participants with overweight/obesity and normoglycemia, prediabetes, or type 2 diabetes: secondary analyses of pooled data from the SCALE clinical development program

Phase 3 trials are much larger (thousands of participants), longer (often 2+ years), and are the stage required for regulatory approval

In vivo tests on healthy volunteers (Schirra et al., 2002) have shown that GLP-1 increases gastric volume, reduces food consumption, and inhibits gastric emptying

[DOI] [PubMed] [Google Scholar] 9

Adopt a Balanced and Nutrient-Dense Diet : A crucial component of successful weight loss is adopting a balanced and nutrient-dense diet